Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Fulcrum Therapeutics
FULC
$283M
| $415K | ﹤0.01% |
113,319
+2,194
| +2% | +$13.3K |
2023 Q4
10 quarters
|
|
3252
Neumora Therapeutics
NMRA
$69M
| $413K | ﹤0.01% |
243,195
+37,266
| +18% | +$70.9K |
2024 Q2
8 quarters
|
|
3253
SIGA Technologies
SIGA
$218M
| $412K | ﹤0.01% |
113,091
+1,573
| +1% | +$7.04K |
2019 Q3
27 quarters
|
|
3254
WisdomTree International MidCap Dividend Fund
DIM
$158M
| $412K | ﹤0.01% |
4,829
-335
| -6% | -$29K |
2013 Q2
52 quarters
|
|
3255
Avalo Therapeutics
AVTX
$385M
| $411K | ﹤0.01% |
+22,226
| New | +$351K |
2026 Q2
0 quarters
|
|
3256
Organogenesis Holdings
ORGO
$98.8M
| $410K | ﹤0.01% |
168,904
+6,167
| +4% | +$15.1K |
2020 Q4
22 quarters
|
|
3257
Larimar Therapeutics
LRMR
$257M
| $410K | ﹤0.01% |
134,483
+114,836
| +584% | +$456K |
2023 Q4
10 quarters
|
|
3258
Everspin Technologies
MRAM
$332M
| $408K | ﹤0.01% |
+16,867
| New | +$378K |
2026 Q2
0 quarters
|
|
3259
Vista Energy
VIST
$7.79B
| $408K | ﹤0.01% |
6,391
+927
| +17% | +$65.3K |
2026 Q1
1 quarter
|
|
3260
Nuveen Multi-Asset Income Fund
NMAI
$457M
| $408K | ﹤0.01% |
28,773
+499
| +2% | +$6.86K |
2025 Q3
3 quarters
|
|
3261
Abivax
ABVX
$7.58B
| $408K | ﹤0.01% |
3,058
-123,362
| -98% | -$14M |
2025 Q4
2 quarters
|
|
3262
Jade Biosciences
JBIO
$894M
| $403K | ﹤0.01% |
18,119
-11,441
| -39% | -$239K |
2025 Q3
3 quarters
|
|
3263
Hudson Technologies
HDSN
$181M
| $402K | ﹤0.01% |
70,075
-8,711
| -11% | -$49.6K |
2022 Q1
17 quarters
|
|
3264
TORM
TRMD
$4.38B
| $400K | ﹤0.01% |
15,365
-1,576
| -9% | -$47.7K |
2025 Q2
4 quarters
|
|
3265
OmniAb
OABI
$745M
| $397K | ﹤0.01% |
161,376
+26,289
| +19% | +$52.2K |
2022 Q4
14 quarters
|
|
3266
Invivyd
IVVD
$171M
| $397K | ﹤0.01% |
454,530
+74,118
| +19% | +$92.9K |
2024 Q2
8 quarters
|
|
3267
Inogen
INGN
$182M
| $396K | ﹤0.01% |
61,388
+5,281
| +9% | +$34.9K |
2015 Q2
44 quarters
|
|
3268
Accelerant Holdings
ARX
$4.3B
| $395K | ﹤0.01% |
+33,735
| New | +$474K |
2026 Q2
0 quarters
|
|
3269
Bel Fuse Inc Class A
BELFA
$2.73B
| $395K | ﹤0.01% |
+1,355
| New | +$329K |
2026 Q2
0 quarters
|
|
3270
Richardson Electronics
RELL
$294M
| $394K | ﹤0.01% |
20,750
+1,703
| +9% | +$26.6K |
2024 Q1
9 quarters
|
|
3271
Beyond Meat
BYND
$119M
| $394K | ﹤0.01% |
17,506
-12,089
| -41% | -$282K |
2019 Q2
28 quarters
|
|
3272
Jefferson Capital
JCAP
$1.13B
| $393K | ﹤0.01% |
+20,195
| New | +$377K |
2026 Q2
0 quarters
|
|
3273
Quantum-Si Incorporated
QSI
$320M
| $393K | ﹤0.01% |
443,929
+37,239
| +9% | +$35.5K |
2022 Q2
16 quarters
|
|
3274
iShares MSCI EAFE ETF
EFA
$76.7B
| $392K | ﹤0.01% |
3,778
-7,311
| -66% | -$752K |
2024 Q2
8 quarters
|
|
3275
RCI Hospitality Holdings
RICK
$216M
| $391K | ﹤0.01% |
14,307
-1,386
| -9% | -$35.1K |
2017 Q1
37 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.